Introducing AutoML framework for drug-drug interaction prediction: application of AutoGluon

Drug-drug interactions (DDIs) remain a major concern in medication safety. Although advanced artificial intelligence methods such as deep learning have improved DDI prediction, their adoption is limited by the need for specialized expertise and complex model development. This study introduces the first application of the AutoGluon AutoML framework to DDI prediction using molecular features, aiming to automate and simplify model development. A curated subset of 100,000 drug pairs from DrugBank was used, employing three molecular representations: 2D molecular descriptors, 2048-bit Morgan fingerprints, and their combination. Models were trained using AutoGluon-Tabular with no manual hyperparameter tuning. The descriptor-only model achieved the best performance, with 84.4% test accuracy and an AUC of 0.916, outperforming fingerprint-based and hybrid models. Feature importance analysis identified key physicochemical and topological descriptors-such as drug-likeness, electrotopological indices, and hydrophobic surface area-as critical predictors of DDIs. These results demonstrate that AutoML can extract chemically meaningful patterns while reducing technical barriers. Overall, our results validate AutoGluon as a scalable approach to DDI prediction that provides chemically meaningful, feature-level interpretability, and lay the groundwork for future applications involving larger datasets and more complex chemical representations.